Reuters: Arts

viernes, 12 de septiembre de 2014

Reuters Health Report

Click to View in Browser
09/12/2014
Reuters Election 2012 Daily round-up of the day's top news from the campaign trail, the White House and all the politics in between
As Ebola grows out of control, WHO pleads for more health workers
LONDON/GENEVA (Reuters) - The number of new Ebola cases in West Africa is growing faster than authorities can manage them, the World Health Organization (WHO) said on Friday, renewing a call for health workers from around the world to go to the region to help.
BAT's novel e-cigarette rival wins UK medical approval
LONDON (Reuters) - A new nicotine inhaler to be sold by British American Tobacco has been licensed in the UK as a medicinal product, marking the arrival of a novel alternative to the fast-growing market for electronic cigarettes.
U.S. FDA panel: Novo Nordisk's liraglutide safe, effective for obesity
WASHINGTON (Reuters) - Novo Nordisk's drug liraglutide is safe and effective enough to warrant approval for use in chronically obese patients with at least one weight-related health issue, an advisory panel to the U.S. Food and Drug Administration concluded on Thursday.
As Big Tobacco takes up e-cigarettes, investors look ahead
LONDON/NEW YORK (Reuters) - As electronic cigarettes flew off shelves on both sides of the Atlantic in recent years, investors flocked to a business some hope will be the future for tobacco.
Third U.S. Ebola patient showing 'remarkable improvement'
CHICAGO (Reuters) - The third American to be treated for Ebola in the United States is showing "remarkable improvement" after receiving an infusion of plasma from U.S. Ebola survivor Dr. Kent Brantly, as well as an undisclosed experimental drug, his doctors said on Thursday.
Merck KGaA ends lung cancer vaccine trials
FRANKFURT (Reuters) - German drugmaker Merck KGaA drug stopped all remaining clinical studies of the experimental lung cancer vaccine tecemotide, formerly known as Stimuvax, after renewed attempts to show its effectiveness failed.
Cuba to send 165 health workers to fight Ebola in Africa
GENEVA (Reuters) - Cuba is to send 165 healthcare workers to West Africa to help in the battle against the world's worst ever epidemic of the Ebola virus, the country's health minister said on Friday.
Health developers, doctors want to see more from Apple's watch
SAN FRANCISCO (Reuters) - Technology pundits were quick to predict the demise of most fitness wristbands and smartwatches when Apple Inc launched its Apple Watch. But healthcare professionals and fitness junkies were left wanting to see more.
Exclusive : Microsoft co-founder Allen to give $9 million for Ebola fight
NEW YORK (Reuters) - Microsoft Corp co-founder Paul Allen's charitable foundation on Thursday will announce it is donating $9 million to support U.S. efforts to fight the Ebola outbreak in West Africa, a source familiar with the matter said.
Scientists 'reset' stem cells to study start of human development
LONDON (Reuters) - British and Japanese scientists have managed to "reset" human stem cells to their earliest state, opening up a new realm of research into the start of human development and potentially life-saving regenerative medicines.
Related Video
Wireless charging technology comes to Formula-E racing
Bacteria-treated honey cures wounds and offers antibiotic resistance hope
SUBSCRIBE TO OTHER REUTERS NEWSLETTERS
 Reuters Deals Today
The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today  
Reuters Business Today
A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today  
» MORE NEWSLETTERS
- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters
Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details
Subscribe to other Reuters newsletters.
Unsubscribe from this newsletter.
Follow us on Twitter facebook Friend us on Facebook Forward this newsletter to a friend Forward to a friend

No hay comentarios:

Publicar un comentario